Anil K Agarwal Selected Research

Cholecystitis

10/2023	Xanthogranulomatous cholecystitis with histologic features suggestive of IgG4 related cholecystitis - A morphologic overlap with IgG4 related disease.
1/2013	p53 and beta-catenin expression in gallbladder tissues and correlation with tumor progression in gallbladder cancer.
4/2011	Xanthogranulomatous cholecystitis: a premalignant condition?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anil K Agarwal Research Topics

Disease

15	Lipodystrophy 01/2024 - 06/2003
12	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2023 - 05/2002
12	Pathologic Constriction (Stenosis) 01/2021 - 01/2007
11	Neoplasms (Cancer) 01/2023 - 11/2006
9	Chronic Renal Insufficiency 04/2021 - 01/2002
9	Anemia 04/2021 - 11/2006
7	Inflammation (Inflammations) 04/2021 - 11/2006
6	Insulin Resistance 04/2024 - 12/2005
6	Obesity 01/2014 - 07/2003
5	Progeria (Hutchinson Gilford Syndrome) 10/2020 - 02/2006
5	Gallbladder Neoplasms (Gallbladder Cancer) 01/2019 - 10/2007
4	Iron Deficiencies 04/2021 - 11/2006
3	Cholecystitis 10/2023 - 04/2011
3	Hyperglycemia 01/2022 - 01/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2007
3	Hypertriglyceridemia 01/2022 - 12/2005
3	Arteriovenous Fistula 11/2020 - 01/2008
3	Portal Hypertension 10/2015 - 08/2008
3	Heart Failure 01/2013 - 07/2010
2	Sepsis (Septicemia) 11/2023 - 12/2015
2	Werner Syndrome (Werner's Syndrome) 10/2023 - 12/2005
2	Fibrosis (Cirrhosis) 10/2023 - 09/2021
2	Panniculitis 01/2023 - 12/2010
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2004
2	Osteoporosis 08/2020 - 03/2008
2	Carcinogenesis 08/2019 - 01/2011
2	Body Weight (Weight, Body) 11/2017 - 01/2007
2	Muscular Dystrophies (Muscular Dystrophy) 09/2017 - 02/2006
2	Cardiomyopathies (Cardiomyopathy) 09/2017 - 02/2006
2	Type 2 Diabetes Mellitus (MODY) 07/2017 - 01/2004
2	Infections 11/2015 - 05/2012
2	Adenocarcinoma 07/2015 - 10/2007
2	Kidney Diseases (Kidney Disease) 06/2013 - 01/2013
2	Chronic Kidney Failure (Chronic Renal Failure) 03/2012 - 05/2006
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2011 - 08/2010
2	Hyperplasia 09/2009 - 01/2008
2	Carcinoma (Carcinomatosis) 12/2007 - 10/2007
2	Chronic Pancreatitis 10/2007 - 01/2003
2	Familial Partial Lipodystrophy (Dunnigan Syndrome) 05/2003 - 01/2002
1	Liver Diseases (Liver Disease) 01/2024
1	Renal Insufficiency (Renal Failure) 11/2023
1	Xanthogranulomatous cholecystitis 10/2023
1	Immunoglobulin G4-Related Disease 10/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2023

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 12/2019 - 05/2003
10	Lamin Type A (Lamin A)IBA 10/2020 - 05/2003
9	Insulin (Novolin)FDA Link 04/2024 - 12/2005
7	EnzymesIBA 12/2016 - 07/2003
6	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 09/2010
5	HematinicsIBA 04/2021 - 03/2009
5	IronIBA 04/2021 - 07/2010
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2024 - 07/2003
4	Biomarkers (Surrogate Marker)IBA 04/2021 - 07/2010
4	ZincIBA 06/2009 - 08/2003
4	Metalloproteases (Metalloproteinases)IBA 06/2009 - 08/2003
3	CreatinineIBA 01/2022 - 11/2006
3	1-Acylglycerol-3-Phosphate O-Acyltransferase (1 Acylglycerol 3 Phosphate O Acyltransferase)IBA 10/2020 - 10/2003
3	LipidsIBA 01/2019 - 08/2009
3	Phosphotransferases (Kinase)IBA 01/2017 - 01/2006
3	Hemoglobins (Hemoglobin)IBA 03/2012 - 11/2006
3	Erythropoietin FDA Link 07/2010 - 11/2006
3	Caveolin 1IBA 06/2009 - 04/2008
3	PPAR gammaIBA 06/2009 - 01/2002
3	Triglycerides (Triacylglycerol)IBA 01/2006 - 05/2002
2	Heparin (Liquaemin)FDA LinkGeneric 11/2023 - 05/2012
2	AutoantibodiesIBA 01/2023 - 03/2009
2	HepcidinsIBA 04/2021 - 01/2019
2	Cathepsin DIBA 01/2021 - 01/2019
2	LeptinIBA 02/2014 - 10/2003
2	CytokinesIBA 01/2014 - 01/2013
2	CausticsIBA 10/2013 - 11/2012
2	Monoclonal AntibodiesIBA 01/2013 - 04/2011
2	beta CateninIBA 01/2013 - 04/2011
2	ParaffinIBA 01/2013 - 04/2011
2	Protein Isoforms (Isoforms)IBA 08/2012 - 08/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 09/2010 - 09/2008
2	Messenger RNA (mRNA)IBA 08/2010 - 01/2004
2	Darbepoetin alfa (Aranesp)FDA Link 03/2009 - 05/2008
2	GlucocorticoidsIBA 03/2008 - 01/2004
2	Indicators and Reagents (Reagents)IBA 12/2007 - 10/2007
2	prelamin AIBA 06/2006 - 09/2005
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2006 - 01/2006
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2024
1	SolutionsIBA 11/2023
1	taurolidineIBA 11/2023
1	NucleotidesIBA 10/2023
1	Immunoglobulin G (IgG)IBA 10/2023
1	Perilipin-1IBA 01/2023

Therapy/Procedure

12	Therapeutics 02/2023 - 04/2005
9	Renal Dialysis (Hemodialysis) 11/2023 - 01/2007
8	Catheters 11/2023 - 01/2007
5	Cholecystectomy 10/2023 - 04/2012
3	Central Venous Catheters 11/2023 - 01/2007
3	Splenectomy 04/2012 - 10/2007
2	Endovascular Procedures 01/2019 - 09/2009
2	Stents 12/2015 - 09/2009
2	Esophagectomy 06/2013 - 01/2013
2	Kidney Transplantation 06/2013 - 05/2006
2	Pancreaticoduodenectomy 03/2012 - 01/2003
1	Immunotherapy 01/2023